CSI Market
Sign In | Register

Abbvie Inc (ABBV) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access ABBV quarterly Cash Flow →
By examining cash flow figures across successive periods, users can identify shifts in Abbvie Inc's cash generation and deployment strategy.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income4,233.00
Depreciation & amortization762.00
Amortization of Other Assets7,377.00
Special charges0.00
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability6,495.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories-234.00
Purchased in-process R & D0.00
Gain (Loss) on Disposition of Other Assets0.00
Share-based Compensation955.00
Sharebased compensation0.00
Foreign Currency Transaction Loss, before Tax0.00
Impairment Of Intangible Assets Excluding Goodwill847.00
Upfront Costs Related To Collaborations5,016.00
Research And Development Asset Acquired Other Than Through Business Combination Written Off-
Payment For Contingent Consideration Liability Operating Activities-2,865.00
Income taxes-1,254.00
Prepaid expenses0.00
Increase (Decrease) in Accounts Receivable-1,490.00
Increase (Decrease) in Accounts Payable and Accrued Liabilities951.00
Losses/ -gains on investments net0.00
Post-retirement benefits expense0.00
Increase (Decrease) in Prepaid Expense and Other Assets-827.00
Other Working Capital0.00
Other Noncash Income (Expense)-3.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-933.00
Discontinued operations0.00
Net Cash flow from Operating Activities19,030.00
Investing Activities
Capital Expenditures-1,214.00
Sale of Capital Items0.00
Short-term investments liq.0.00
Payments to Acquire Marketable Securities-35.00
Proceeds from other investments0.00
Purchases of other investments0.00
Noncontrolling interest0.00
Proceeds from Investments0.00
Payments to Acquire Other Investments-5,161.00
Purchases of non-current assets0.00
Payments to Acquire Businesses, Net of Cash Acquired-204.00
Investment in affiliate0.00
Sale of businesses0.00
Proceeds from sale of assets0.00
Restricted funds0.00
Payments for (Proceeds from) Other Investing Activities-29.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-6,643.00
Financing Activities
Short-term debt Net2,499.00
Other borrowing transactions-23.00
Long-term debt - borrowings3,994.00
Long-term debt - repayments-6,797.00
Noncontrolling interest0.00
Issuances / -repurchases of Comm. Stock-808.00
Exercise of stock options0.00
Issuances / -repurchases of Pref. Stock0.00
Discontinued Operations0.00
Other financing activities net0.00
Other net68.00
Dividends paid to minority interests0.00
Dividends paid-11,657.00
Net Cash Flow from Financing Activities-12,724.00
Effect of exchange rate on cash flow42.00
Discontinued operations0.00
Free Cash Flow17,816.00
Total Cash Flow-295.00
4 historic quarters locked

Sign in to unlock the full Abbvie Inc cash flow history.

Sign In Create Free Account

About Abbvie Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 20, 2026
  • Source: abbv-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001551152-26-000008

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License